(Q37803116)

23 August 2017

0 references

Characterizing the profile of obese patients who are metabolically healthy (English)

1 reference

23 August 2017

0 references

0 references

7

1 reference

23 August 2017

V Primeau

1

1 reference

23 August 2017

L Coderre

2

1 reference

23 August 2017

A D Karelis

3

1 reference

23 August 2017

M Brochu

4

1 reference

23 August 2017

M-E Lavoie

5

1 reference

23 August 2017

V Messier

6

1 reference

23 August 2017

R Rabasa-Lhoret

8

1 reference

23 August 2017

language of work or name

English

0 references

publication date

26 October 2010

1 reference

International Journal of Obesity

23 August 2017

1 reference

23 August 2017

35

1 reference

23 August 2017

7

1 reference

23 August 2017

971-981

1 reference

https://scigraph.springernature.com/pub.10.1038/ijo.2010.216

23 August 2017

0 references

cites work

Prevalence and trends in obesity among US adults, 1999-2008

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

The distinction of metabolically 'healthy' from 'unhealthy' obese individuals

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Metabolically healthy but obese individuals

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

The metabolically healthy but obese individual presents a favorable inflammation profile

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Metabolic and body composition factors in subgroups of obesity: what do we know?

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Are there persons who are obese, but metabolically healthy?

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

High adiponectin concentrations are associated with the metabolically healthy obese phenotype

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Are natural killer cells protecting the metabolically healthy obese patient?

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Identification and characterization of metabolically benign obesity in humans

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

The "obese insulin-sensitive" adolescent: importance of adiponectin and lipid partitioning

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Metabolically Healthy but Obese Women Have an Intermediate Cardiovascular Risk Profile Between Healthy Nonobese Women and Obese Insulin-Resistant Women

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Inclusion of C-reactive protein in the identification of metabolically healthy but obese (MHO) individuals

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Not all obese subjects of multiethnic origin are at similar risk for developing hypertension and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Inflammation in subcutaneous adipose tissue: relationship to adipose cell size.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

The concept of cardiometabolic risk: Bridging the fields of diabetology and cardiology

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Determinants of insulin-resistant phenotypes in normal-weight and obese Black African women

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Metabolically healthy but obese individuals: relationship with hepatic enzymes

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Increased whole-body adiposity without a concomitant increase in liver fat is not associated with augmented metabolic dysfunction.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Contribution of the lean body mass to insulin resistance in postmenopausal women with visceral obesity: a Monet study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Association of insulin sensitivity and muscle strength in overweight and obese sedentary postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Discrimination between obesity and insulin resistance in the relationship with adiponectin

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Association of acylated and nonacylated ghrelin with insulin sensitivity in overweight and obese postmenopausal women.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Effects of acute hyperinsulinaemia on total and high-molecular-weight adiponectin concentration in metabolically healthy but obese postmenopausal women: a Montreal-Ottawa New Emerging Team (MONET) study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

The relationship between active ghrelin levels and human obesity involves alterations in resting energy expenditure

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Relationship between ghrelin and energy expenditure in healthy young women.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Receptors for insulin-like growth factor-I in plasma membranes isolated from bovine mesenteric arteries

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

The effect of including C-reactive protein in cardiovascular risk prediction models for women.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Psychosocial profile of the metabolically healthy but obese postmenopausal woman.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

High birth weight and early postnatal weight gain protect obese children and adolescents from truncal adiposity and insulin resistance: metabolically healthy but obese subjects?

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Insulin resistance associated with lower rates of weight gain in Pima Indians

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Insulin resistance: an adaptation for weight maintenance

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Intensive lifestyle changes are necessary to improve insulin sensitivity: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Effects of weight loss among metabolically healthy obese men and women

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Differentiation between obesity and insulin resistance in the association with C-reactive protein

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Physical activity, the Framingham risk score and risk of coronary heart disease in men and women of the EPIC-Norfolk study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Metabolically healthy but obese women: effect of an energy-restricted diet

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Insulin resistance syndrome, body mass index and the risk of ischemic heart disease

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Are metabolically normal but obese individuals at lower risk for all-cause mortality?

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

The effect of randomization to weight loss on total mortality in older overweight and obese adults: the ADAPT Study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Long-term mortality after gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Identifying metabolically healthy but obese individuals in sedentary postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Adipose cell size and glucose tolerance in obese children and effects of diet

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Studies of human adipose tissue. Adipose cell size and number in nonobese and obese patients

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Adipose-cell size and immunoreactive insulin levels in obese and normal-weight adults

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Insulin resistance, adipocyte biology, and thiazolidinediones: a review

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Adipogenic human adenovirus Ad-36 induces commitment, differentiation, and lipid accumulation in human adipose-derived stem cells

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Metabolically favorable remodeling of human adipose tissue by human adenovirus type 36.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Increased adiposity in animals due to a human virus

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Human adenovirus Ad-36 promotes weight gain in male rhesus and marmoset monkeys

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Human adenovirus 36 induces adiposity, increases insulin sensitivity, and alters hypothalamic monoamines in rats.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Microarray profiling of human skeletal muscle reveals that insulin regulates approximately 800 genes during a hyperinsulinemic clamp

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Influence of obesity and insulin sensitivity on insulin signaling genes in human omental and subcutaneous adipose tissue

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Acute in vivo effects of insulin on gene expression in adipose tissue in insulin-resistant and insulin-sensitive subjects

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Prevalence of uncomplicated obesity in an Italian obese population

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.216

7 January 2021

Identifiers

DOI

10.1038/IJO.2010.216

1 reference

Dimensions Publication ID

23 August 2017

0 references

1 reference